BioCentury
ARTICLE | Finance

Dermagraft redux

Advanced BioHealing proposes IPO to raise up to $200M

February 28, 2011 8:00 AM UTC

Profitable wound healing play Advanced BioHealing Inc. proposed late Friday to raise up to $200 million in an IPO.

The company markets Dermagraft, a human fibroblast-derived skin substitute, to treat full-thickness diabetic foot ulcers...